In this weeks video, Dr. Brian G.M. Durie explains why genetic sequencing tests are not yet precise enough to use for choosing myeloma therapies.
BOTTOM LINE:
We may be able to specify myeloma treatments based on genetic subtypes in the future, but not quite yet!